Drug Information

Drug General Information
Drug ID
D0H7OP
Former ID
DNC013771
Drug Name
N-allylnorlitebamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [534555]
Structure
Download
2D MOL

3D MOL
Formula
C22H23NO4
Canonical SMILES
COC1=C(C=C2C=CC3=C(C2=C1)C(=C(C4=C3CCN(C4)CC=C)O)OC)O
InChI
1S/C22H23NO4/c1-4-8-23-9-7-14-15-6-5-13-10-18(24)19(26-2)11-16(13)20(15)22(27-3)21(25)17(14)12-23/h4-6,10-11,24-25H,1,7-9,12H2,2-3H3
InChIKey
GFTFQCRSRIGURP-UHFFFAOYSA-N
PubChem Compound ID
10546795
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [534555]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 534555J Nat Prod. 1998 Jan;61(1):46-50.Litebamine N-homologues: preparation and anti-acetylcholinesterase activity.
Ref 534555J Nat Prod. 1998 Jan;61(1):46-50.Litebamine N-homologues: preparation and anti-acetylcholinesterase activity.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.